Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age

by Malkin, Elissa, Yogev, Ram, Abughali, Nazha, Sliman, Joseph, Wang, C. Kathy, Zuo, Fengrong, Yang, Chin-Fen, Eickhoff, Mark, Esser, Mark T., Tang, Roderick S., Dubovsky, Filip
Published 2013

Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum Malaria

by Malkin, Elissa, Long, Carole A, Stowers, Anthony W, Zou, Lanling, Singh, Sanjay, MacDonald, Nicholas J, Narum, David L, Miles, Aaron P, Orcutt, Andrew C, Muratova, Olga, Moretz, Samuel E, Zhou, Hong, Diouf, Ababacar, Fay, Michael, Tierney, Eveline, Leese, Philip, Mahanty, Siddhartha, Miller, Louis H, Saul, Allan, Martin, Laura B
Published 2007

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians

by Dicko, Alassane, Diemert, David J., Sagara, Issaka, Sogoba, Moussa, Niambele, Mohamed B., Assadou, Mahamadoun H., Guindo, Ousmane, Kamate, Beh, Baby, Mounirou, Sissoko, Mady, Malkin, Elissa M., Fay, Michael P., Thera, Mahamadou A., Miura, Kazutoyo, Dolo, Amagana, Diallo, Dapa A., Mullen, Gregory E., Long, Carole A., Saul, Allan, Doumbo, Ogobara, Miller, Louis H.
Published 2007

A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720

by McCarthy, James S., Marjason, Joanne, Elliott, Suzanne, Fahey, Paul, Bang, Gilles, Malkin, Elissa, Tierney, Eveline, Aked-Hurditch, Hayley, Adda, Christopher, Cross, Nadia, Richards, Jack S., Fowkes, Freya J. I., Boyle, Michelle J., Long, Carole, Druilhe, Pierre, Beeson, James G., Anders, Robin F.
Published 2011